Medication info
Amorex Tablet 625 mg

Amorex Tablet 625 mg

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
CTC Bio, Co., Ltd.
Appearance
This medicine is an oval-shaped film-coated tablet that is white or nearly white.
Packaging
40 tablets (4 tablets/PTP packaging*10)
Approval status
Active

MFDS item code 201603598 · Approved 2016.06.20 · Insurance code 669502000

Summary

Main use
Treatment of respiratory, ear, nose, and throat; genitourinary; skin; bone; and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dosage adjustments are based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
CTC Bio, Co., Ltd.

Efficacy & effects

Treatment of respiratory, ear, nose, and throat; genitourinary; skin; bone; and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchial pneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medicine is used for the treatment of various infections caused by bacteria. It is effective for respiratory infections such as acute and chronic bronchitis, lobar and bronchial pneumonia, tonsillitis, sinusitis, and otitis media. It also treats urinary tract infections such as cystitis, urethritis, and pyelonephritis, as well as sexually transmitted diseases such as pelvic infections and gonorrhea. It helps in the treatment of skin abscesses, cellulitis, and wound infections. This medicine is also used in the treatment of osteomyelitis and dental infections. It is used to improve various infections.

How to take

Adult dose

The dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dosage adjustments are based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. 10 mL/min or less: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours or 500mg/125mg of amoxicillin/potassium clavulanate per dose. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Precautions

This medicine is a beta-lactam antibiotic and should not be used in patients with hypersensitivity to penicillin or cephalosporin drugs. Especially patients with viral infections such as infectious mononucleosis or lymphocytic leukemia are at higher risk of rash and should be careful. Patients with a history of liver dysfunction or jaundice should also avoid use due to the risk of recurrence. Patients with impaired liver function or severe renal impairment may have increased drug concentrations, so dosage and administration intervals should be adjusted. Care should be taken when using this medicine in patients with allergic tendencies, elderly patients, or patients who have difficulty swallowing orally, as there may be a risk of bleeding due to vitamin K deficiency. Patients with gastrointestinal diseases may have unstable drug absorption, so caution is needed. This medicine can cause gastrointestinal side effects such as diarrhea, vomiting, and abdominal pain, and in severe cases, pseudomembranous colitis may occur, so treatment should be stopped immediately and medical consultation should be sought if symptoms appear. Long-term use may cause elevated liver enzyme levels or symptoms of hepatitis, so regular liver function tests should be conducted. Rarely, serious skin reactions or anaphylactic shock may occur. If symptoms such as rash or difficulty breathing occur, treatment should be stopped immediately and emergency measures should be taken. Blood tests may show abnormalities such as leukopenia or anemia, so any unusual symptoms should be reported to the hospital. There have been rare reports of central nervous system disturbances such as anxiety, headache, and seizures, requiring special caution in patients with reduced kidney function. Regular checks on renal function should be conducted, and treatment should be halted if necessary. This medicine may interact with other medications, so it is essential to inform healthcare providers of any other medications being taken. Use during the early stages of pregnancy or while pregnant is restricted, and caution is needed while breastfeeding as it may affect the baby. It is not recommended for children under 12 years of age or those weighing less than 40 kg. Elderly patients may experience side effects more easily due to reduced physical function, so dosages and administration intervals should be adjusted, and their condition closely monitored. This medicine should be stored in a dry place at temperatures below 25 degrees, and in case of overdose, gastrointestinal symptoms and renal and neurological abnormalities may occur, requiring immediate medical attention.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, fecal urgency, dry mouth, acute pancreatitis, candidiasis, antibiotic-associated colitis, severe colitis with hematochezia, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized pustular psoriasis, drug reactions associated with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, dyspnea with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, vaginal burning, increased discharge, agitation, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, antispasmodic agents, fever, nausea, vomiting, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B deficiency, linear IgA disease, taste disturbances, malaise, dermatitis, oral edema, stomach pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial brain convulsions, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to prevent moisture infiltration, and it is advisable to keep it in a cool place between 1 and 25 degrees. Proper storage helps maintain the medication's effectiveness for a long time.

Appearance and packaging

Appearance

This medicine is an oval-shaped film-coated tablet that is white or nearly white.

Package unit

40 tablets (4 tablets/PTP packaging*10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.